KORU Medical Systems, Inc. (NASDAQ: KRMD)

KORU Medical Systems, Inc. (KRMD) is a prominent player in the healthcare sector, specializing in the provision of innovative and patient-centric large volume subcutaneous infusion solutions. The company's primary business activities revolve around mechanical infusion products, with a particular focus on the FREEDOM Infusion Systems. These systems are designed to deliver life-saving therapies to patients with chronic illnesses, such as Primary Immunodeficiency Diseases (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). The FREEDOM System's portability, ease of operation, and maintenance-free nature make it an ideal solution for patients requiring subcutaneous drug delivery.

KORU Medical Systems generates revenue from three primary sources: domestic core, international core, and novel therapies. The domestic core revenue is derived from the sale of syringe drivers, tubing, and needles for the delivery of subcutaneous drugs that are FDA-cleared for use with the FREEDOM System. The international core revenue is generated from the sale of the FREEDOM System in countries outside of the United States. The novel therapies revenue comes from the sale of products and services related to the development and commercialization of new subcutaneous infusion therapies.

In the highly competitive subcutaneous infusion market, KORU Medical Systems holds a significant position. The company's competitive advantages include its innovative and patient-centric approach, strong relationships with pharmaceutical companies and specialty pharmacies, and its adaptability to changing market trends and regulatory requirements. Notable competitors in this space include Becton, Dickinson and Company (BDX), Smiths Medical (SMM), and ICU Medical, Inc. (ICUI).

KORU Medical Systems' customers include pharmaceutical companies, specialty pharmacies, and ambulatory service providers. These customers purchase the FREEDOM System and related products and services from KORU Medical Systems, which are then used to deliver subcutaneous therapies to patients.

The company's product portfolio includes the FREEDOM60 Syringe Driver, FreedomEdge Syringe Driver, HIgH-Flo Subcutaneous Safety Needle Sets, and Precision Flow Rate Tubing. These products are designed to provide safe, effective, and convenient subcutaneous infusion solutions for patients with chronic illnesses.

In terms of human capital resources, KORU Medical Systems has a diverse workforce of 82 full-time employees, including 3 international employees. The company invests in its employees by providing training opportunities and maintaining a dedicated Internet-based learning platform with a broad portfolio of policy and training materials.